Our findings demonstrate that TSLP-stimulated CD4+ T cell immunity blocks breast cancer promotion by engulfing primary breast tumors and transforming them into low-grade, fibrocystic structures, with no metastatic potential. This evidence concerns the gene TSLP and breast carcinoma.